Novo Nordisk Is Selling Ozempic for $24 a Week in India. Why It’s So Cheap.

Novo Nordisk launched Ozempic in India on Friday—and the weight-loss drug will sell at a massive discount there, compared ...

Why Novo Nordisk Stock Topped the Market on Thursday

A proposed new federal law could provide some competitive guardrails for the company's most important product.

Lexicon Pharmaceuticals Announces Publication of Preclinical Data in the Journal of the Endocrine Society on Acyl-CoA Synthetase 5 (ACSL5) Reinforcing the Scientific Rationale ...

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the publication of preclinical data validating Acyl-CoA Synthetase 5 (ACSL5) as a target for obesity and chronic weight management. The ...
TipRanks on MSN

Lexicon announces publication of preclinical data on ACSL5

Lexicon Pharmaceuticals (LXRX) announced the publication of preclinical data validating Acyl-CoA Synthetase 5 as a target for obesity and chronic ...
C&EN

Looming GLP-1 drug patent expirations draw generics firms

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Industry experts ...